跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72,514 条关于
“pan-phosphoinositide 3-kinase”
全部
72,514
临床试验
51,306
药物
5,534
机构
1,528
资讯
14,146
去年
Adlai Nortye's AN2025 Shows Promise in Head and Neck Cancer Treatment
去年
Pharming Group Initiates Phase II Trial of Leniolisib for Primary Immunodeficiencies
去年
Adlai Nortye's Buparlisib Poised to Potentially Be First PI3K Inhibitor for Head and Neck Cancer
去年
Pharming's Leniolisib Shows Positive Phase 3 Data in Young Children with APDS
去年
MHRA Approves Joenja (leniolisib) as First Treatment for Rare Immune Disease APDS
11个月前
Pharming Group to Present 12 Studies on Rare Disease Treatments at 2025 ACAAI Meeting
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
11个月前
FDA Grants Priority Review for Leniolisib in Children with Rare Immunodeficiency APDS
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Significantly Improve Outcomes in Advanced Breast Cancer
第 1 页，共 1415 页
上一页
下一页
